Tag: Chemotherapy
Endocrine Therapy Lowers QOL for Breast Cancer Patients
Effects of chemotherapy found to be more transient in comparison
Secondary Surgical Cytoreduction Not Superior in Ovarian Cancer
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer
Gilteritinib Superior in Relapsed, Refractory FLT3-Mutated AML
Overall survival significantly longer, percentage of remission higher than with salvage chemotherapy
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course
Algorithm Based on Response, Biology Guides Neuroblastoma Tx
Survival excellent with treatment algorithm for children with intermediate-risk neuroblastoma
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure
Delay in Time to Chemo Impacts Survival in Breast Cancer
Time interval from diagnosis to surgery has largest impact on time from diagnosis to chemo initiation
Light Therapy May Prevent Oral Mucositis for Some in Cancer Tx
Laser, other light tx recommended for patients treated with HSCT; head and neck RT with, without chemo
High Response Seen for Chemo in Seniors With High-Risk AML
Complete response rate for patients treated with chemo was 69 percent; three-year OS was 21 percent
